Farr Miller & Washington’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
MVP
IAM
Farr Miller & Washington's PGEN Position: Q4 2018 in Review
Farr Miller & Washington sold out of Precigen (PGEN) in Q4 2018, closing a stake of 48,164 shares — an estimated $829K sold.
Farr Miller & Washington first reported a position in PGEN in Q1 2018 and held it in 3 quarters. The position peaked at $982K in Q1 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q4 2018.
- Farr Miller & Washington reported no remaining Precigen position as of Q4 2018 after selling out during the quarter.
- Farr Miller & Washington sold 48,164 Precigen shares in Q4 2018, an estimated $829K.
- Farr Miller & Washington first reported a position in Precigen in Q1 2018 and held it in 3 quarters.
- Farr Miller & Washington's Precigen position peaked at $982K in Q1 2018.
- 166 funds tracked by Wall St. Rank held Precigen as of Q4 2018.
Based on Farr Miller & Washington's 13F filing for Q4 2018, filed 14 Feb 2019.